|
HS Code |
940263 |
| Generic Name | Cefuroxime Sodium |
| Drug Class | Second-generation cephalosporin antibiotic |
| Chemical Formula | C16H15N4NaO8S |
| Molecular Weight | 446.37 g/mol |
| Appearance | White to off-white crystalline powder |
| Route Of Administration | Intravenous or intramuscular injection |
| Indications | Bacterial infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
| Storage Conditions | Store below 25°C, protect from light |
| Contraindications | Hypersensitivity to cephalosporins or penicillins |
As an accredited Cefuroxime Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging contains 1g Cefuroxime Sodium, sealed in a sterile glass vial, with tamper-evident cap and labeled for intravenous use. |
| Shipping | Cefuroxime Sodium is shipped in tightly sealed, light-resistant containers under controlled room temperature. Packages are clearly labeled, compliant with safety and transport regulations, and include necessary documentation. Special care is taken to protect against moisture and contamination, ensuring stability and integrity during transit. Temperature monitoring is provided if required. |
| Storage | Cefuroxime Sodium should be stored in a well-closed container, protected from light and moisture. It must be kept at a temperature below 25°C (77°F) and should not be frozen. The storage area should be dry and well-ventilated, away from incompatible substances. Reconstituted solutions should be used promptly or stored as directed in the product labeling. |
|
Purity 98.5%: Cefuroxime Sodium with a purity of 98.5% is used in intravenous formulations, where it ensures consistent antibacterial efficacy against susceptible pathogens. Particle Size D90 < 15 µm: Cefuroxime Sodium with particle size D90 less than 15 µm is used in parenteral suspensions, where it provides rapid and uniform dissolution profiles. Stability at 25°C: Cefuroxime Sodium with stable properties at 25°C is used in long-term pharmaceutical storage, where it maintains potency throughout shelf life. Water Content < 2.0%: Cefuroxime Sodium with water content less than 2.0% is used in sterile dosage preparations, where low moisture minimizes hydrolysis and degradation risks. Endotoxin Level < 0.5 IU/mg: Cefuroxime Sodium with endotoxin levels below 0.5 IU/mg is used in injectable antibiotics, where it reduces pyrogenic reactions in clinical treatments. Melting Point 156-158°C: Cefuroxime Sodium with a melting point range of 156-158°C is used in precision tableting processes, where it enables optimal compaction and drug release. Assay ≥ 99.0%: Cefuroxime Sodium with assay values above 99.0% is used in high-dose intravenous formulations, where it provides accurate and reliable dosing for severe infections. Solubility > 100 mg/mL in water: Cefuroxime Sodium with solubility greater than 100 mg/mL in water is used in reconstitutable vials, where it ensures fast preparation and clear solutions. Residual Solvent < 0.5%: Cefuroxime Sodium with residual solvent levels below 0.5% is used in compliant pharmaceutical manufacturing, where it meets regulatory safety requirements. pH (4.0-6.0): Cefuroxime Sodium with a pH range of 4.0-6.0 is used in buffered injectable solutions, where it provides optimal drug stability and patient compatibility. |
Competitive Cefuroxime Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In today’s medical landscape, older antibiotics still play a huge role. It’s easy to see an endless stream of new treatments and forget the value in what already works. Cefuroxime Sodium is a time-tested injectable antibiotic that hospitals and clinics have counted on for decades. Pharmacists reach for it, not out of habit, but from clinical experience and clear results. It pulls its weight in the fight against a wide range of bacterial infections, from pneumonia to urinary tract infections.
No medical product succeeds for this long on reputation alone. The science backs it up. People working in infection control tell stories of outbreaks managed effectively with drugs like Cefuroxime Sodium, especially in areas where resistant bacteria have chipped away at other options. The formula has gone through industry scrapes and regulatory review, but it remains a reliable backbone in antibiotic protocols.
Typical Cefuroxime Sodium vials contain lyophilized powder that’s meant for dissolving right before use. The medicine gets prepared fresh for each patient, maximizing its effectiveness and minimizing the risk of contamination. Pharmacies tend to stock several strengths, but 750mg and 1.5g vials are the most common. The bright-white powder dissolves into a clear solution, which care teams inject into veins or muscles. This versatility gives clinicians control over how quickly or slowly the drug reaches the bloodstream.
From my own work with hospital teams, I’ve seen how much thought goes into choosing the right antibiotic. Some patients need rapid results, while others require dosing adjustments based on kidney function, age, or underlying medical conditions. Cefuroxime Sodium’s range of administration options helps teams meet those real-world needs. Its well-understood pharmacokinetics and broad experience in clinical situations make troubleshooting easier, especially when compared with newer, less-studied alternatives.
Anyone who’s worked in a busy emergency department knows that time matters. Cefuroxime Sodium can be reconstituted at the bedside and administered with confidence, since allergic reactions to cephalosporins are well-characterized and rare compared to penicillins. Dosing is straightforward. Nurses rarely spend time checking obscure compatibility charts—the drug plays well with standard saline and glucose solutions.
Doctors often lean toward Cefuroxime Sodium in “unknown origin” infections. For example, a patient comes in with a high fever, a worryingly low blood pressure, and no obvious cause. Instead of losing time on endless tests, infection control protocols kick in. Cefuroxime Sodium covers many of the most common hospital and community bacteria, giving teams a safety net while further diagnostics continue. Hospitals in rural or resource-limited areas appreciate its predictable profile and reasonable storage needs—no refrigeration needed before reconstitution in most settings.
Antibiotic resistance is a growing threat that shakes the foundation of modern medicine. Once-simple infections risk becoming untreatable. One might think the answer always lies in newer drugs, but experience often points the other way. Cefuroxime Sodium is a “second-generation” cephalosporin, and its use is strategic: doctors turn to it when first-line drugs lose their punch, yet don’t want to go straight to the newest and most expensive options.
Broad-spectrum doesn’t mean recklessly broad. There’s data behind each recommendation. Research has shown that sensible use of drugs like Cefuroxime Sodium helps lighten the load on newer antibiotics, slowing the pace of resistance. In a hospital setting, aggressive surveillance and regular review of drug choices keep Cefuroxime Sodium working where it counts, without inviting unnecessary side effects or encouraging stubborn, resistant strains.
From working with stewardship teams, the key lesson is that older antibiotics are not obsolete. Young pharmacists and physicians often come in thinking they need to use the biggest “gun” available, but experienced mentors show where classic drugs like Cefuroxime Sodium still outmatch flashier alternatives. They ride that balance between coverage and conservation, leaving patients safer and the wider community less exposed to the fallout of unchecked resistance.
Cefuroxime Sodium’s safety record is more than a stack of clinical trial data. Nurses who have delivered thousands of doses remember the handful of times a patient experienced a reaction, but those moments are the exceptions, not the rule. Allergic reactions remain infrequent, especially against a backdrop of beta-lactam antibiotics. For most patients, the shot produces little more than a mild sting or swelling—no more bothersome than many other injectables.
As for side effects, gastrointestinal problems pop up from time to time: loose stools, nausea, and the rare yeast infection. Most people move through a course of Cefuroxime Sodium without a second thought, and patients with tougher infections appreciate a drug that works without the baggage of harsh side effects. Those caring for older patients—or kids—find reassurance in Cefuroxime Sodium’s track record. Overdoses rarely cause more than mild symptoms, and doctors feel comfortable using the drug in more vulnerable groups once they’ve checked for true cephalosporin allergies.
Healthcare providers face tough calls every day. Ease of use, safety, and predictable outcomes make a strong case for sticking with proven options like Cefuroxime Sodium, especially in emergencies or resource-stretched environments.
Cefuroxime Sodium plays a part in many treatment guidelines. Community-acquired pneumonia, skin and soft tissue infections, surgical prophylaxis, and urinary tract infections all appear in the list of recognized uses. Surgeons reach for it during operations to head off infections before they start. In the hands of infectious disease teams, it acts as a stable partner for other medications, delivering broad bacterial coverage without too many surprises.
The World Health Organization includes Cefuroxime Sodium on its List of Essential Medicines for a reason. Decision-makers working in public health trust it to do the job safely and efficiently. In places facing steady surges of infectious diseases, Cefuroxime Sodium earns its keep by staying effective against common foes like Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. In the outpatient world, doctors use it to treat harder-to-shake ear, nose, and throat infections and even some forms of meningitis when given intravenously.
I’ve seen clinical settings from well-resourced urban hospitals to rural outposts that get one truckload of medical supplies per month. Cefuroxime Sodium shows up in both places: accessible, shelf-stable, and responsive to a wide range of evolving needs without the red tape that comes with newer, costlier treatments.
The shelves in hospital pharmacies hold a dizzying lineup of antibiotics. Each drug promises a mix of strengths and tradeoffs: spectrum of activity, how long they linger in the body, risk of side effects, and cost. Cefuroxime Sodium, in action, comes across as an all-rounder. Not too aggressive. Not too meek. For daily infections that call for an intravenous antibiotic, it offers dependable performance.
Compared with first-generation cephalosporins, Cefuroxime Sodium steps up the game by tackling a wider pool of bacteria, including some that have learned to dodge older drugs. But it doesn’t swing so wide as to wipe out healthy bacteria indiscriminately—a problem flagged by infectious disease experts with stronger, newer broad-spectrum drugs. This helps keep superbugs in check and lowers the odds of collateral damage in patients.
Oral cefuroxime exists, but the sodium salt for injection holds a special place. In life-and-death scenarios where oral medications can’t cut it, this injectable form offers speed and flexibility. It’s what surgeons often reach for before pinning a fracture or opening an abdomen, since it batters possible invaders without gumming up the recovery process. Nurses and doctors alike trust the product for consistency from one batch to another, building confidence that each dose works just as expected.
Other antibiotics such as carbapenems or glycopeptides bring higher potency but come loaded with extra risk or cost. They demand careful monitoring, extra paperwork, and sometimes, more intensive preparation. Cefuroxime Sodium keeps things manageable—just basic equipment and water for injection do the trick. This matters on hospital floors packed with patients and during disaster relief missions where time and sterile resources run thin.
Every powerful medicine needs proper stewardship. Doctors and pharmacists work together behind the scenes, reviewing usage patterns and calibrating protocols. For Cefuroxime Sodium, this involves knowing when to use it—and when to hold back. Over the years, stewardship programs have trimmed excessive and routine use, aiming to keep bacteria guessing. Narrow-spectrum drugs take the lead for obvious infections, but when the situation clouds over or several possibilities fit the clues, Cefuroxime Sodium provides a reasonable hedge.
Some clinics and hospitals put safeguards in their ordering systems, prompting a brief consultation or diagnosis check before green-lighting broad-spectrum antibiotics like Cefuroxime Sodium. Education helps, especially for those just beginning their careers. Preceptors make a point of walking students through case studies that highlight both the benefits and responsibilities tied to each prescription. Responsible use keeps the drug useful for others—a lesson hammered home in places where drug-resistant infections have upended standard care.
Trust in a medicine grows from more than clinical success. Pharmaceutical companies put Cefuroxime Sodium through rigorous testing. Quality assurance teams pull random batches and run them through chemical purity and sterility checks. Regulators step in frequently, sending inspectors and reviewing factory processes. The endgame is consistent—patients receive exactly what their doctors intend, with no surprises. Raw ingredients must be traceable, and contamination gets zero tolerance.
Supply chain disruptions pose a threat from time to time, especially in smaller markets or remote hospitals. During those moments, the dependability of basic medicines comes into sharp focus. Some hospitals have weathered storms of national shortages, having to conserve doses or substitute less proven alternatives. Teams with experience in crisis response advocate for robust stockpiles of vital drugs like Cefuroxime Sodium, emphasizing the dangers of leaning too heavily on a small pool of alternatives.
Modern antibiotics grew out of urgent need and sometimes desperate measures. Healthcare providers, with the wisdom of decades behind them, push for measured, intentional change. They value drugs like Cefuroxime Sodium for their transparency and predictability. Instead of constantly chasing the new, the medical field holds onto the importance of judging treatments by track record, not just by novelty.
Pharmacist training often includes hands-on work with lyophilized antibiotics like Cefuroxime Sodium, teaching practical skills for preparation and dosing. Simulation labs run mock code blues where students mix and deliver this drug under pressure, learning subtleties they’ll use for years. This generational handoff cements the antibiotic’s role far beyond textbooks or clinical algorithms.
Payers and health systems pressure clinicians to consider costs. Cefuroxime Sodium, made in many countries, keeps competition high and pricing within reach. This democratizes access, giving less wealthy regions a shot at the same standard of care enjoyed by bigger cities. During global emergencies, charitable organizations often include Cefuroxime Sodium on shipment lists for disaster areas, citing its mix of effectiveness, safety, and shelf-stability.
Antibiotics rarely generate headlines unless something goes wrong—an outbreak, a recall, a resistance cluster that outsmarts every available drug. Behind the scenes, teams rely every day on unsung champions like Cefuroxime Sodium, using clinical judgment to strike the right balance between eradicating infection and preserving long-term effectiveness. It’s a push-and-pull dynamic: too much antibiotic use invites trouble, too little risks patient safety.
Hospitals have responded with more robust tracking and feedback. I once worked on a project that followed antibiotic orders from pharmacy shelf to patient bedside and then to stewardship review. Cefuroxime Sodium prescriptions stood out for clear documentation, guided by established protocols. This transparency, enforced by wise policies, keeps patient safety in sharp focus while staying one step ahead of antibiotic resistance.
No product survives this long without a share of problems. The biggest challenge facing Cefuroxime Sodium lies outside its own chemistry: It’s the growing number of bugs learning to evade even time-tested treatments. The answer lies in teamwork rather than chemistry alone. Team-based stewardship programs that review every broad-spectrum antibiotic order, real-time bacterial susceptibility testing, and ongoing nurse and physician education all contribute. Hospitals and practices that invest in these efforts see lower rates of resistance and fewer days spent on ineffective medications.
Global challenges mean no one solution fits every setting. Some rural clinics still lack access to real-time lab support. Investment in regional labs, telemedicine connections, and strong transport systems help bring the benefits of responsible Cefuroxime Sodium use beyond city limits. Countries with stronger regulatory oversight set an example for safeguarding supplies and keeping substandard products off the market. International partnerships—sharing resistance trends and best practices—raise the floor for everyone dependent on classic antibiotics.
For longtime healthcare providers, Cefuroxime Sodium is a familiar face in a shifting world of bacterial threats. Its balanced profile, ease of use, and consistent impact on common infections explain its staying power. Many lives saved by this antibiotic don’t show up in dramatic headlines, but each uneventful recovery tells a quiet story of success. In the rush to move forward, it’s worth pausing to see the steady value in proven solutions—backed by experience and ongoing vigilance.
Preserving the usefulness of drugs like Cefuroxime Sodium comes down to wise use, sharp monitoring, and a commitment to learning from both success and failure. Bringing new tools to market is important, but so is holding on to what works. In hospitals across the world, Cefuroxime Sodium does its job—patient by patient, dose by dose—reminding us that sometimes, reliability is innovation’s equal.